Cancer Cachexia Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Feb 2018| TMR210A| Transparency

Report Highlights

Global Cancer Cachexia Market: Overview

This report on the cancer cachexia market analyzes the current and future scenario of the global market. Growth of the global cancer cachexia market is driven by high investments made in cutting-edge drug research resulting in new, sophisticated treatments with specific mechanism of action. Moreover, rising emphasis on palliative cancer care will further boost the market in near future. The cancer cachexia market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market.

It also provides information and data analysis of the global market with respect to the segments based on therapeutics, mechanism of action, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the cancer cachexia market.

Global Cancer Cachexia Market: Segmentation

The global cancer cachexia market has been analyzed on the basis of therapeutics, mechanism of action, distribution channels and geography. Major therapeutics segments are progestogens, corticosteroids combination therapies, others. The others segment of global cancer cachexia market includes pipeline therapeutic approach. Thus the market of others segment has been considered as addressable market. According to mechanism of action, market is segmented in to appetite stimulators, weight loss stabilizers, and other mode of actions. Hospital stores, retail pharmacy stores, online pharmacy are considered as preferred distribution channels.

The market is driven by argumentative lifestyle habits leading to lung cancer, rising incidence rate of cachexia mainly in the developed region like the U.S., Europe and Japan. Moreover, increasing funding for cancer research by government and private organizations, increased awareness about palliative care will further the demand for cancer cachexia drugs in near future. While, stringent regulatory requirements and long procedure for FDA approval have discouraged cancer cachexia drug manufacturers. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Cancer Cachexia Market: Regional Outlook

Geographically, the global cancer cachexia market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global cancer cachexia market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in the women’s health market are – Æterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corporation, Eli Lilly and Company, GTx, Inc., Helsinn Group, Merck & Co., Inc., Novartis AG, Bristol-Myers Squibb Company, and XBiotech, Inc.

The global cancer cachexia market has been segmented as follows:

By Therapeutics

Progestogens
Corticosteroids
Combination Therapies
Others
By Mechanism of action

Appetite Stimulators
Weight Loss Stabilizers
Others
By Distribution Channel

Hospital Stores
Retail Pharmacy Stores
Online Pharmacy
By Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia and New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of MEA

  • Table 1 : Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
  • Table 2 : Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
  • Table 3 : Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 4 : Global Cancer Cachexia Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 5 : North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 6 : North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
  • Table 7 : North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
  • Table 8 : North America Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 9 : Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 10 : Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
  • Table 11 : Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
  • Table 12 : Europe Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 13 : Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 14 : Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
  • Table 15 : Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
  • Table 16 : Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 17 : Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 18 : Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
  • Table 19 : Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
  • Table 20 : Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 21 : Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 22 : Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Therapeutics, 2015–2025
  • Table 23 : Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Mechanism of Action, 2015–2025
  • Table 24 : Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Figure 1 : Global Progestogens Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 2 : Global Corticosteroids Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 3 : Global Combination Therapies Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 4 : Global Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2015–2025
  • Figure 5 : Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 6 : Global Appetite Stimulators Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 7 : Global Weight Loss Stabilizers Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 8 : Global Others Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 9 : Global Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2015–2025
  • Figure 10 : Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Mechanism of Action, 2016 and 2025
  • Figure 11 : Global Hospital Stores Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 12 : Global Retail Pharmacy Stores Market Value (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 13 : Global Online Pharmacy Value Market (US$ Mn) and Y-o-Y Growth (%) Projection, 2015–2025
  • Figure 14 : Global Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2015–2025
  • Figure 15 : Global Cancer Cachexia Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 16 : Global Cancer Cachexia Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 17 : Global Cancer Cachexia Market Attractiveness Analysis, by Region
  • Figure 18 : North America Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 19 : North America Cancer Cachexia Market Attractiveness Analysis, by Country
  • Figure 20 : North America Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 21 : North America Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 22 : North America Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
  • Figure 23 : North America Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 24 : North America Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
  • Figure 25 : North America Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
  • Figure 26 : North America Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
  • Figure 27 : Europe Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 28 : Europe Cancer Cachexia Market Attractiveness Analysis, by Country
  • Figure 29 : Europe Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 30 : Europe Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 31 : Europe Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
  • Figure 32 : Europe Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 33 : Europe Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
  • Figure 34 : Europe Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
  • Figure 35 : Europe Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
  • Figure 36 : Asia Pacific Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 37 : Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Country
  • Figure 38 : Asia Pacific Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 39 : Asia Pacific Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 40 : Asia Pacific Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
  • Figure 41 : Asia Pacific Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 42 : Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
  • Figure 43 : Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
  • Figure 44 : Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
  • Figure 45 : Latin America Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 46 : Latin America Cancer Cachexia Market Attractiveness Analysis, by Country
  • Figure 47 : Latin America Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 48 : Latin America Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 49 : Latin America Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
  • Figure 50 : Latin America Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 51 : Latin America Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
  • Figure 52 : Latin America Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
  • Figure 53 : Latin America Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
  • Figure 54 : Middle East & Africa Cancer Cachexia Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 55 : Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Country
  • Figure 56 : Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 57 : Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 58 : Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2016 and 2025
  • Figure 59 : Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 60 : Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Therapeutics
  • Figure 61 : Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action
  • Figure 62 : Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel
  • Figure 63 : Æterna Zentaris, Inc., Net Sales, by Region, 2016
  • Figure 64 : Æterna Zentaris, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
  • Figure 65 : Æterna Zentaris, Inc., Breakdown of Net Sales, by Product, 2016
  • Figure 66 : Æterna Zentaris, Inc., Research and Development Cost, 2016 and 2015 (Thousands)
  • Figure 67 : Alder BioPharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2014, 2016
  • Figure 68 : Alder BioPharmaceuticals, Inc., Research and Development Cost, 2016 and 2015 (Thousands)
  • Figure 69 : Eli Lilly and Company, Net Sales, by Region, 2016
  • Figure 70 : Eli Lilly and Company, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 71 : Eli Lilly and Company, Breakdown of Net Sales, by Business Segment, 2016
  • Figure 72 : Eli Lilly and Company, Research and Development Cost, 2016 and 2015 (US$ Mn)
  • Figure 73 : Merck & Co., Inc., Net Sales, by Region, 2016
  • Figure 74 : Merck & Co., Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
  • Figure 75 : Merck & Co., Inc., Breakdown of Net Sales, by Business segment, 2016
  • Figure 76 : Merck & Co., Inc., Research and Development Cost, 2016 and 2015 (US$ Bn)
  • Figure 77 : Novartis AG, Net Sales, by Region, 2016
  • Figure 78 : Novartis AG, Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
  • Figure 79 : Novartis AG, Breakdown of Net Sales, by Business segment, 2016
  • Figure 80 : Novartis AG, Breakdown of Net Sales, by Business Units, 2016
  • Figure 81 : Bristol-Myers Squibb Company, Net Sales, by Region, 2016
  • Figure 82 : Bristol-Myers Squibb Company, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
  • Figure 83 : Bristol-Myers Squibb Company, Breakdown of Net Sales, by Business segment, 2016
  • Figure 84 : Bristol-Myers Squibb Company, Research and Development Cost, 2016 and 2015 (US$ Mn)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report